Effects of branched-chain-enriched amino acid solution on insulin and glucagon secretion and blood glucose level in liver cirrhosis

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 8, 1998, Pages 853-859

  Tabaru, A ^a   Shirohara, H ^a   Moriyama, A ^a   Otsuki, M ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Branched chain amino acids; Glucagon; Hypoglycemia; Insulin; Liver cirrhosis

Indexed keywords

BRANCHED CHAIN AMINO ACID; GLUCOSE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; LIVER CIRRHOSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; AGED; AMINO ACIDS, BRANCHED-CHAIN; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCAGON; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; LIVER CIRRHOSIS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0031719716     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850171521     Document Type: Article

References (29)

1. Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB. The effect of normalized of plasma amino acids on hepatic encephalopathy in man. Surgery 1976;80:77-91.
2. Morioka S, Kanai K, Kato M, Nakajima T, Yoshimi T, Masaka M, et al. Effects of branched chain amino acid infusion on glucose metabolism in cirrhotic patients with encephalopathy. Gastroenterol Jpn 1983;18:553-9.
3. Maddrey WC. Branched chain amino acid therapy in liver disease. J Am Coll Nutr 1985;4:639-50.
4. Floyd JC Jr, Fajans SS, Conn JW, Knopf RF, Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest 1966;45:1487-502.
5. Ohneda A, Aguilar-Parada E, Eisentraut AM, Unger RH. Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids. J Clin Invest 1968;47:2305-22.
6. Rocha DM, Faloona GR, Unger RH. Glucagon-stimulating activity of 20 amino acids in dogs. J Clin Invest 1972;51:2346-51.
7. Kuhara T, Ikeda S, Ohneda A, Sasaki Y. Effects of intravenous infusion of 17 amino acids on the secretion of GH, glucagon, and insulin in sheep. Am J Physiol 1991;260:E21-6.
8. Otsuki M, Sakamoto C, Hosi Y, Maeda M, Morita S, Ohki A, et al. Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas. J Clin Invest 1979;63:478-84.
9. Sorenson RL, Elde RP. Dissociation of glucose stimulation of somatostatin and insulin release from glucose inhibition of glucagon release in the isolated perfused rat pancreas. Diabetes 1983;32:561-7.
10. Unger RH. Glucagon and insulin:glucagon ratio in diabetes and other catabolic illness. Diabetes 1971;20:834-8.
11. Megyesi C, Samols E, Marks V. Glucose tolerance and diabetes in chronic liver disease. Lancet 1967;2:1051-5.
12. Petrides AS, De-Fronzo RA. Glucose metabolism in cirrhosis: a review with some perspectives for the future. Diabet Metab Rev 1989;5:691-709.
13. Petrides AS, Schulze-Berge D, Vogt C, Matthews S, Strohmeyer G. Glucose resistance contributes to diabetes mellitus in cirrhosis. Hepatology 1993;18:284-91.
14. Gentile S, Loguercio C, Marmo R, Carbone L, Del-Vecchio-Blanco C. Incidence of altered glucose tolerance in liver cirrhosis. Diabet Res Clin Pract 1993;22:37-44.
15. Petrides AS, Vogt C, Schulze-Berge D, Matthews D, Strohmeyer G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 1994;19:616-27.
16. Nolte W, Hartmann H, Ramadori G. Glucose metabolism and liver cirrhosis. Exp Clin Endocrinol Diabet 1995;103:63-74.
17. Uemura K, Sakato M, Miyahara H, Takei M, Akou S, Yanagisawa Y, et al. A case of liver cirrhosis with portal calcification associated with hypoglycemia induced by branched chain amino acid solution. Jpn J Gastroenterol 1993;90:2127-31 (in Japanese).
18. Pugh RNH, Murray-Layon IM, Dawson JL, Pietroni MC, Williams R. Transection of the esophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
19. Record CO, Buxton B, Chase RA, Curzon G, Murray-Lyon IM, Willams R. Plasma and brain amino acids in fluminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest 1976;10:387-94.
20. Morgan MY. Branched chain amino acids in the management of chronic liver disease. Facts and fantasies. J Hepatol 1990;11: 133-41.
21. Sanjo K, Yamasaki M. Early phase II study of MHS-2; amino acids solution for hepatic encephalopathy. Pharmacol Ther 1991;19:195-206 (in Japanese).
22. Watanabe A, Hayashi S, Shiota T, Nagashima H. Comparative study of amino acid, ammonia and pancreatic hormone levels in the blood of cirrhotic patients following intravenous administration of a branched-chain amino acid-enriched solution. Acta Med Okayama 1983;37:441-5.
23. Parrilla R, Goodman MN, Toews CJ. Effect of glucagon: insulin ratios on hepatic metabolism. Diabetes 1974;23:725-31.
24. Müller MJ, Willmann O, Rieger A, Fenk A, Selberg O, Lautz HU, et al. Mechanism of insulin resistance associated with liver cirrhosis. Gastroenterology 1992;102:2033-41.
25. Chen M, Bergman RN, Porte D Jr. Insulin resistance and beta-cell dysfunction in aging: the importance of dietary carbohydrate. J Clin Endocrinol Metab 1988;67:951-7.
26. Pagano G, Marena S, Scaglione L, Bodoni P, Montegrosso G, Bruno A, et al. Insulin resistance shows selective metabolic and hormonal targets in elderly. Eur J Clin Invest 1996;26:650-6.
27. Silva G, Gomis R, Bosch J, Casamitjana R, Mastai R, Navasa M, et al. Hyperglucagonism and glucagon resistance in cirrhosis. Paradoxical effect of propranolol on plasma glucagon levels. J Hepatol 1988;6:325-31.
28. Keller U, Sonnoenberg GE, Burckhardt D, Perruchoud A. Evidence for an augmented glucagon dependence of hepatic glucose production in cirrhosis of the liver. J Clin Endocrinol Metab 1982;54:961-8.
29. Petrides AS, De-Fronzo RA. Failure of glucagon to stimulate hepatic glycogenolysis in well-nourished patients with mild cirrhosis. Metabolism 1994;43:85-9.